Dana-Farber Cancer Institute, Center for Community-Based Research, 450 Brookline Avenue, LW601, Boston, MA 02215 USA.
Transl Behav Med. 2013 Jun;3(2):211-7. doi: 10.1007/s13142-013-0202-7.
Smoking among childhood and young adult cancer survivors may increase risk for late effects of treatment, and survivors need assistance in quitting. This paper reports on the prevalence of discussions between childhood cancer survivors and their health care providers about smoking cessation and pharmacotherapy and explores factors that are associated with these discussions. This is a longitudinal study that included 329 smokers who were childhood or young adult cancer survivors, recruited from five cancer centers in the USA and Canada. Fifty-five percent of smokers reported receiving advice to quit smoking from their regular provider during the study period, and only 36 % of smokers reported discussing pharmacotherapy with their provider. Receipt of advice was associated with being female and having a heavier smoking rate. Pharmacotherapy discussions were associated with readiness to quit, heavier smoking rate, and previous provider advice to quit. Health care providers are missing key opportunities to advise cancer survivors about cessation and evidence-based interventions. Systematic efforts are needed to ensure that survivors who smoke get the treatment that they need.
吸烟在儿童和青年癌症幸存者中可能会增加治疗后出现副作用的风险，幸存者需要帮助戒烟。本文报告了儿童癌症幸存者与他们的医疗保健提供者之间关于戒烟和药物治疗的讨论的流行情况，并探讨了与这些讨论相关的因素。这是一项纵向研究，包括来自美国和加拿大的五家癌症中心的 329 名吸烟者。在研究期间，55%的吸烟者报告说从他们的常规提供者那里获得了戒烟建议，但只有 36%的吸烟者报告与他们的提供者讨论了药物治疗。接受建议与女性和更高的吸烟率有关。药物治疗讨论与戒烟的准备程度、吸烟率以及之前提供者建议戒烟有关。医疗保健提供者错过了向癌症幸存者提供戒烟和基于证据的干预措施的关键机会。需要系统地努力，以确保吸烟的幸存者得到他们需要的治疗。
